CACNA1A and undifferentiated pancreatic carcinoma: In ELISA, 125 (86%) of BI+ patients showed a positive anti-PGL-I titer, in the UCP-LFA 136 (94%) and in the Gold-LFA 114 (78%) (Fig. 3).